The present invention relates to novel oxime derivatives of the general formula (I), their tautomeric forms, their stereoisomers, their pharmaceutically acceptable salts, pharmaceutical compositions containing them, methods for their preparation, use of these compounds in medicine and the intermediates involved in their preparation.
本发明涉及一种新型
肟衍
生物,其一般式为(I),它们的互变异构体,立体异构体,药学上可接受的盐,包含它们的制药组合物,制备它们的方法,这些化合物在医学上的应用以及制备它们所涉及的中间体。